salen has been researched along with Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carradori, S; Celik, G; Ceruso, M; D'Ascenzio, M; De Monte, C; Scozzafava, A; Secci, D; Supuran, CT; Vullo, D | 1 |
Amemiya, N; Aoki, I; Eguchi, H; Fukumura, H; Hirata, K; Hoshino, Y; Inoue, S; Ishikawa, Y; Kim, JH; Kurotani, R; Lee, J; Masuda, T; Sato, I; Sato, M; Singh, DJ; Tanigaki, K; Umemura, M; Urano, T; Yamamoto, M; Yoshida, K | 1 |
Rabindra Reddy, P; Shilpa, A | 1 |
Dvořák, Z; Sindelář, Z; Starha, P; Trávníček, Z | 1 |
4 other study(ies) available for salen and Neoplasms
Article | Year |
---|---|
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Drug Design; Enzyme Activation; Ethylenediamines; Humans; Neoplasms; Phenol; Polyamines; Protein Binding; Protein Isoforms; Structure-Activity Relationship | 2013 |
A magnetic anti-cancer compound for magnet-guided delivery and magnetic resonance imaging.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Ethylenediamines; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Molecular Structure; Neoplasms | 2015 |
Synthesis, characterization, and DNA-binding and -cleavage properties of dinuclear Cu(II) --salophen/salen complexes.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cattle; Copper; DNA; DNA Cleavage; Ethylenediamines; Models, Molecular; Neoplasms; Organometallic Compounds; Salicylates; Schiff Bases | 2011 |
Evaluation of in vitro cytotoxicity of one-dimensional chain [Fe(salen)(L)](n) complexes against human cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Stability; Ethylenediamines; Ferric Compounds; Humans; Inhibitory Concentration 50; Neoplasms; Solvents; Spectrophotometry, Ultraviolet | 2012 |